Patent · US Active

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

US11000498B2 · kind B2 · utility

34Cited by

43References

20Claims

0Family size

Assignee

Flamel Ireland Limited · IE

Inventors

Claire Mégret · L'Essart Mador, FR
Hervé Guillard · Villeurbanne, FR
Jean-François Dubuisson · L'Essart Mador, FR
Julien Grassot · L'Essart Mador, FR

Key dates

Filing date	Jun 4, 2019
Grant date	May 11, 2021
Priority date	—
Expiry date	Jun 4, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/19
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.